Cargando…
Clostridium Histolyticum Collagenase Underdosed for Multicord Injection in Dupuytren’s Disease: A Retrospective Cohort Study
An underdosing of collagenase clostridium histolyticum (0.32 mg) is proposed as a potentially effective option in patients with additional cords in the same hand, after the first cord has been treated with the regular dose of 0.58 mg. The aim of this study was to analyze whether this additional dose...
Autores principales: | Boriani, Filippo, Raggini, Filippo, Evangelista, Andrea, Gustar, Adrian, Figus, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682618/ https://www.ncbi.nlm.nih.gov/pubmed/36438471 http://dx.doi.org/10.1097/GOX.0000000000004659 |
Ejemplares similares
-
Can You Go the Distance: Collagenase Clostridium histolyticum Manipulation at 1 Month after Injection
por: Pflibsen, Lacey R., et al.
Publicado: (2023) -
Dupuytren Disease: A Retrospective Cohort Study Comparing Collagenase Injection and Percutaneous Needle Fasciotomy
por: Mehdiyev, Turkhan, et al.
Publicado: (2022) -
Multiple concurrent collagenase clostridium histolyticum injections to dupuytren’s cords: an exploratory study
por: Coleman, Stephen, et al.
Publicado: (2012) -
Collagenase Clostridium Histolyticum Injection for Dupuytren Contracture: 2-Year Follow-up
por: Nayar, Suresh K., et al.
Publicado: (2019) -
The emerging role of Clostridium histolyticum collagenase in the treatment of Dupuytren disease
por: Thomas, Alexis, et al.
Publicado: (2010)